Protara Therapeutics, Inc. (TARA)
 NASDAQ: TARA · Real-Time Price · USD
 5.14
 -0.06 (-1.15%)
  At close: Oct 30, 2025, 4:00 PM EDT
5.18
 +0.04 (0.78%)
  After-hours: Oct 30, 2025, 7:10 PM EDT
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $198.31 million as of October 30, 2025. Its market cap has increased by 428.83% in one year.
Market Cap 
 198.31M
Enterprise Value 
 56.65M
1-Year Change 
 428.83%
Ranking 
 Category 
 Stock Price 
$5.14
Market Cap Chart
Since October 22, 2014, Protara Therapeutics's market cap has increased from $140.90M to $198.31M, an increase of 40.75%. That is a compound annual growth rate of 3.15%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 200.60M | 84.21% | 
| Dec 31, 2024 | 108.90M | 411.27% | 
| Dec 29, 2023 | 21.30M | -29.47% | 
| Dec 30, 2022 | 30.20M | -60.16% | 
| Dec 31, 2021 | 75.80M | -72.07% | 
| Dec 31, 2020 | 271.40M | 3,292.50% | 
| Dec 31, 2019 | 8.00M | -81.65% | 
| Dec 31, 2018 | 43.60M | 30.15% | 
| Dec 29, 2017 | 33.50M | 6.35% | 
| Dec 30, 2016 | 31.50M | -87.68% | 
| Dec 31, 2015 | 255.70M | 49.44% | 
| Dec 31, 2014 | 171.10M | 21.43% | 
| Oct 22, 2014 | 140.90M | - | 
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 745.35B | 
| Johnson & Johnson | 453.19B | 
| AbbVie | 402.10B | 
| UnitedHealth Group | 320.60B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 218.86B |